Login
$STIM
$1.29 +$0.04 (3.2%) After hours

$STIM 8-K/A SEC Filings

Filed On Filing
12 Nov 2026 8-K/A: Entry into a Material Definitive Agreement; Other Events
27 Mar 2025 8-K/A: Results of Operations and Financial Condition; Regulation FD Disclosure

MALVERN, PA., March 27, 2025 – Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) is issuing this press release to update the reporting of its financial results for the fourth quarter and full year ending December 31, 2024...

06 Feb 2025 8-K/A: Financial Statements and Exhibits

See accompanying notes to condensed interim consolidated financial statements.

13 Nov 2024 8-K/A: Results of Operations and Financial Condition

MALVERN, PA., November 12, 2024 – In a release issued earlier today under the same headline by Neuronetics, Inc. (NASDAQ: STIM), please note that in the second paragraph of the “Stockholders Approve Acquisition of Greenbrook TMS,” it sho...

20 Oct 2021 8-K/A: Results of Operations and Financial Condition

CORRECTION - Neuronetics Announces Preliminary Revenue for Third Quarter 2021

03 Aug 2021 8-K/A: Results of Operations and Financial Condition

MALVERN, PA., August 3, 2021– Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatr...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support